Globally, the interventional cardiology and peripheral vascular devices market is witnessing high growth due to factors such as rising aging population, rising incidence of cardiovascular diseases, increasing demand of minimally invasive treatments, and technological advancements. Key players are focusing on developing new devices to increase their share in the market. Companies are focusing on the strategies of regulatory approvals, product launches, partnerships and collaborations, acquisitions, and expansions to strengthen their foothold in the market.

Download FREE Brochure @ https://www.marketsandmarkets.com/pdfdownload.asp?id=548

On the basis of product, the interventional cardiology and peripheral vascular devices market is segmented into angioplasty balloons, angioplasty stents, catheters, EVAR stent grafts, IVC filters, plaque modification devices, hemodynamic flow alteration devices, and accessories.

On the basis of type, the angioplasty stents market is segmented into drug-eluting stents, bare-metal stents, and bioabsorbable stents. The rising number of regulatory approvals, technological advancements, and increasing initiatives by companies for new product launches are driving the growth of this market. In 2016, the drug-eluting stents segment is projected to witness the highest growth due to increasing number of regulatory approvals and new product launches.

On the basis of type, the catheters market is segmented into IVUS/OCT, angiography catheters, and guiding catheters. In 2016, the IVUS/OCT segment is projected to witness the highest growth due to increasing penetration rates and rapid advancements & innovations in these systems.

On the basis of type, the EVAR stent grafts market is segmented into abdominal aortic aneurysms and thoracic aortic aneurysms. In 2016, the abdominal aortic aneurysms segment is projected to witness the highest growth due to rising incidence of smoking and hypertension.

In the coming five years, growth in the interventional cardiology and peripheral vascular devices market is likely to be centered in Asia. Growth in this region can be attributed to the rising prevalence of cardiovascular diseases, increasing number of conferences & symposia, and increasing focus of major players on the Asian market.